Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
The trouble with TIGITs: How 'overenthusiasm' led to Big Pharma's risky $6B gamble
Type 1 diabetes
MedTech
Tandem to link pump with Abbott's upcoming glucose-ketone sensor
Tandem Diabetes Care will link its AID systems with an upcoming monitor from Abbott that aims to track both blood glucose and ketone levels.
Conor Hale
Jun 11, 2025 10:31am
Senseonics to link 365-day CGM to Sequel’s upcoming insulin pump
Apr 29, 2025 11:30am
Vertex drops cell-device diabetes combo over poor ph. 1 results
Mar 31, 2025 4:20am
Insulet Type 1 study shows gains in switch to auto insulin pump
Mar 20, 2025 12:12pm
Sana stock price triples after allogeneic cell therapy data drop
Jan 8, 2025 10:38am
Lilly posts more positive data on once-weekly insulin prospect
Sep 11, 2024 2:05pm
